Table 5.
BNF 10-year CHD risk prediction method | ||||||
---|---|---|---|---|---|---|
No. of patients in different risk categories at baseline | No. of patients in different risk categories at 12 months | |||||
<15% | 15–30% | >30% | <15% | 15–30% | >30% | |
Group | (mild) | (moderate) | (severe) | (mild) | (moderate) | (severe) |
Intervention (n (%)) | 76 (63.3%) | 44 (36.7%) | 0 | 100 (85.5%) | 16 (13.7%) | 1 (0.9%) |
Control (n (%)) | 78 (65.0%) | 38 (31.7%) | 4 (3.3%) | 69 (59.0%) | 44 (37.6%) | 4 (3.4%) |
P-value * | 0.125 | <0.001 |
Framingham 10-year CHD risk prediction method | ||||||
---|---|---|---|---|---|---|
No. of patients in different risk categories at baseline | No. of patients in different risk categories at 12 months | |||||
<10% | 10–20% | >20% | <10% | 10–20% | >20% | |
(mild) | (moderate) | (severe) | (mild) | (moderate) | (severe) | |
Intervention (n (%)) | 58 (48.3%) | 60 (50%) | 2 (1.7%) | 80 (68.4%) | 37 (31.6%) | 0 |
Control (n (%)) | 48 (40%) | 71 (59.2%) | 1 (0.8%) | 43 (36.8%) | 74 (63.2%) | 0 |
P-value * | 0.392 | <0.001 |
When comparing control and intervention groups.